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. Flow chart of participant's selection. Table S1 . Participants' characteristics at baseline by type 2 diabetes status at follow-up. Table S2 . Hazard ratio (95% confidence interval) of type 2 diabetes incidence by arsenic metabolism biomarkers (N=1774). In the conventional approach, each arsenic metabolism biomarker is entered alone in the model and the hazard ratios (95% CI) are reported per a 5% increase. In the leave-one-out model, two arsenic metabolism biomarkers are entered in the model. In that model, a 5% increase in each arsenic metabolism biomarker corresponds to a 5% decrease of the biomarker that is left outside the model. Model 1 was stratified by study region and adjusted for gender, age at baseline, baseline education (<12 years, ≥12 years) and log-transformed As concentrations. Model 2 further adjusted for body mass index, waist circumference, smoking status (never, former and current smoker), estimated glomerular filtration rate and fasting glucose status at baseline. Figure S4 . Hazard ratio of type 2 diabetes incidence by arsenic metabolism biomarkers (N=1774). Lines (shaded areas) represent the adjusted hazard ratio (95% confidence intervals) of incident type 2 diabetes based on restricted cubic splines for arsenic metabolism biomarkers with knots at 10th, 50th and 90th percentiles. The reference value was set at 10th percentile of each arsenic metabolism biomarkers distribution. In the left panel, pink line (pink shaded area) represents the hazard ratio for iAs% when it replaces MMA%, and the blue line (blue shaded area) when it replaces DMA%. In the middle panel, pink line (pink shaded area) represents the hazard ratio for MMA% when it replaces iAs%, and the green line (green shaded area) when it replaces DMA%. In the right panel, blue line (blue shaded area) represents the hazard ratio for DMA% when it replaces iAs%, and the green line (green shaded area) when it replaces MMA%. Models were stratified by study region and adjusted for gender, age, education (<12 years, ≥12 years), body mass index, smoking status (never, former and current smoker), waist circumference, glomerular filtration rate, log-transformed As concentrations, estimated dietary vitamin B2, vitamin B6 and folate, AS3MT genotype and fasting glucose levels at baseline. The histograms in the background represent the distributions of arsenic metabolism biomarkers (iAs%, MMA% and DMA%) among the study participants. The extreme tails of the histograms were truncated because 9 participants had iAs% >35, 11 had MMA% >30, 10 had DMA% <45 and 1 had DMA% >95. Figure S5 . Hazard ratio of type 2 diabetes incidence by inorganic arsenic exposure -interaction analysis (N=1838). The hazard ratios of type 2 diabetes incidence were estimated comparing the 75th percentile vs the 25th percentile of As distribution. Model was stratified by study region and adjusted for gender, age, education, body mass index, smoking status, waist circumference, glomerular filtration rate, estimated dietary vitamin B2, vitamin B6 and folate, AS3MT genotype and fasting glucose levels at baseline. The area of each marker is proportional to the subgroup sample size. Abbreviations: HR, Hazard Ratio; CI, confidence interval. Figure S6 . Hazard ratio of type 2 diabetes incidence by arsenic metabolism biomarkers -interaction analysis (N=1774). The hazard ratios of type 2 diabetes incidence were estimated per 5% increase in iAs%, MMA% and DMA%. Models were stratified by study region and adjusted for gender, age, education, body mass index, smoking status, waist circumference, glomerular filtration rate, log-transformed As concentration, estimated dietary vitamin B2, vitamin B6 and folate, AS3MT genotype and fasting glucose levels at baseline. iAs% models were also adjusted for DMA%, then, data in the left panel are the hazard ratios when iAs% replaces MMA%. MMA% models were also adjusted for iAs%, then, data in the middle panel are the hazard ratios when MMA% replaces DMA%. DMA% models were also adjusted for MMA%, then, data in the right panel are the hazard ratios when DMA% replaces iAs%. The area of each marker is proportional to the subgroup sample size. Abbreviations: HR, hazard ratio; CI, confidence interval.
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